---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-012641"
form_type: "8-K"
ticker: "PTN"
cik: "0000911216"
company_name: "PALATIN TECHNOLOGIES INC"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:08:02.993044+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Palatin prices $15.8M public offering; NYSE American listing resumes Nov 12

## Summary
- Priced upsized public offering of 2.43M shares at $6.50/unit; gross proceeds ~$15.8M.
- Series J warrants ($6.50) expire 31 days after FDA accepts IND for obesity program; Series K ($8.125) expire 5 years but terminate early if J not exercised.
- Underwriters granted 45-day option for additional 364,615 shares; closing expected Nov 12, 2025.
- Proceeds to fund obesity program and working capital; potential additional $15.8M upon cash exercise of Series J warrants.
- NYSE American listing resumes Nov 12 under PTN; compliance regained after reverse split and $8.8M revenue from Boehringer Ingelheim.

## SEC filing metadata
- accession: 0001654954-25-012641
- form_type: 8-K
- ticker: PTN
- cik: 0000911216
- company_name: PALATIN TECHNOLOGIES INC
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/911216/000165495425012641/0001654954-25-012641-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/911216/000165495425012641/ptn_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-012641
- JSON: https://secwatch.observer/filing/0001654954-25-012641.json
- Plain text: https://secwatch.observer/filing/0001654954-25-012641.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.